148 related articles for article (PubMed ID: 17611350)
1. Burkholderia cepacia complex: virulence characteristics, importance and relationship with cystic fibrosis.
Coutinho HD
Indian J Med Sci; 2007 Jul; 61(7):422-9. PubMed ID: 17611350
[TBL] [Abstract][Full Text] [Related]
2. [Burkholderia cepacia: dangers of a phytopathogen organism for patients with cystic fibrosis].
Segonds C; Chabanon G
Ann Biol Clin (Paris); 2001; 59(3):259-69. PubMed ID: 11397673
[TBL] [Abstract][Full Text] [Related]
3. Intracellular survival and innate immune evasion of Burkholderia cepacia: Improved understanding of quorum sensing-controlled virulence factors, biofilm, and inhibitors.
Ganesh PS; Vishnupriya S; Vadivelu J; Mariappan V; Vellasamy KM; Shankar EM
Microbiol Immunol; 2020 Feb; 64(2):87-98. PubMed ID: 31769530
[TBL] [Abstract][Full Text] [Related]
4. Burkholderia cepacia complex infection in patients with cystic fibrosis.
Mahenthiralingam E; Baldwin A; Vandamme P
J Med Microbiol; 2002 Jul; 51(7):533-538. PubMed ID: 12132768
[TBL] [Abstract][Full Text] [Related]
5. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis.
De Soyza A; McDowell A; Archer L; Dark JH; Elborn SJ; Mahenthiralingam E; Gould K; Corris PA
Lancet; 2001 Nov; 358(9295):1780-1. PubMed ID: 11734238
[TBL] [Abstract][Full Text] [Related]
6. Identification of Burkholderia cepacia complex pathogens by rapid-cycle PCR with fluorescent hybridization probes.
Vonberg RP; Häußler S; Vandamme P; Steinmetz I
J Med Microbiol; 2006 Jun; 55(Pt 6):721-727. PubMed ID: 16687590
[TBL] [Abstract][Full Text] [Related]
7. [An opportunistic pathogen frequently isolated from immunocompromised patients: Burkholderia cepacia complex].
Baylan O
Mikrobiyol Bul; 2012 Apr; 46(2):304-18. PubMed ID: 22639321
[TBL] [Abstract][Full Text] [Related]
8. Influence of neutrophil defects on Burkholderia cepacia complex pathogenesis.
Porter LA; Goldberg JB
Front Cell Infect Microbiol; 2011; 1():9. PubMed ID: 22919575
[TBL] [Abstract][Full Text] [Related]
9. Burkholderia cepacia complex: impact on the cystic fibrosis lung lesion.
Lynch JP
Semin Respir Crit Care Med; 2009 Oct; 30(5):596-610. PubMed ID: 19760547
[TBL] [Abstract][Full Text] [Related]
10. Advances in Burkholderia cepacia complex.
Speert DP
Paediatr Respir Rev; 2002 Sep; 3(3):230-5. PubMed ID: 12376059
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and clinical course of Burkholderia cepacia complex infections, particularly those caused by different Burkholderia cenocepacia strains, among patients attending an Italian Cystic Fibrosis Center.
Manno G; Dalmastri C; Tabacchioni S; Vandamme P; Lorini R; Minicucci L; Romano L; Giannattasio A; Chiarini L; Bevivino A
J Clin Microbiol; 2004 Apr; 42(4):1491-7. PubMed ID: 15070994
[TBL] [Abstract][Full Text] [Related]
12. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
[TBL] [Abstract][Full Text] [Related]
13. Invasion and intracellular survival of Burkholderia cepacia.
Martin DW; Mohr CD
Infect Immun; 2000 Jan; 68(1):24-9. PubMed ID: 10603364
[TBL] [Abstract][Full Text] [Related]
14. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of Burkholderia cepacia complex species in cystic fibrosis patients in Argentina during the period 2011-2015.
Cipolla L; Rocca F; Martinez C; Aguerre L; Barrios R; Prieto M
Enferm Infecc Microbiol Clin (Engl Ed); 2018; 36(7):431-434. PubMed ID: 29055510
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
Horsley A; Jones AM
Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
[TBL] [Abstract][Full Text] [Related]
17. Misidentification of a genomovar of Burkholderia cepacia by recA restriction fragment length polymorphism.
Moore JE; Millar BC; Xu J; Crowe M; Redmond AO; Elborn JS
J Clin Pathol; 2002 Apr; 55(4):309-11. PubMed ID: 11919219
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
[TBL] [Abstract][Full Text] [Related]
19. Burkholderia cepacia: medical, taxonomic and ecological issues.
Govan JR; Hughes JE; Vandamme P
J Med Microbiol; 1996 Dec; 45(6):395-407. PubMed ID: 8958242
[TBL] [Abstract][Full Text] [Related]
20. Preferential adherence of cable-piliated burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants.
Sajjan U; Wu Y; Kent G; Forstner J
J Med Microbiol; 2000 Oct; 49(10):875-885. PubMed ID: 11023184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
